Glenn Tillotson

Appearances

SAFETY AND EFFICACY OF RBX2660 IN REDUCING RECURRENT <i>CLOSTRIDIOIDES DIFFICILE </i>INFECTION IN IMMUNOCOMPROMISED PARTICIPANTS
Date
May 8, 2023
BACKGROUND: Recurrent _Clostridioides difficile _infection (rCDI) is a debilitating disease associated with significant healthcare burden and low quality of life. The greatest risk factor for rCDI is a history of recurrence, although older age (≥65 years) and comorbidities also increase risk…
Speakers
Erik Dubberke
Monika Fischer
Indiana University-Purdue University Indianapolis
Glenn Tillotson
Monique Bidell
Beth Guthmueller
Frederikke Hoeyer
Presenter
Carolyn Alonso